Carlo J. di Fonzo

Direktor/Vorstandsmitglied bei Vaneltix Pharma, Inc.

Health Technology

Consumer Services

Profil

Carlo J.
di Fonzo is currently a Director at Vaneltix Pharma, Inc. He was previously a Senior VP-Drug Development & Regulatory Affairs at Nektar Therapeutics.
He obtained his undergraduate, graduate, and doctorate degrees from the University of Toronto.

Aktive Positionen von Carlo J. di Fonzo

Unternehmen	Position	Beginn
Vaneltix Pharma, Inc. Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Carlo J. di Fonzo

Ehemalige bekannte Positionen von Carlo J. di Fonzo

Unternehmen	Position	Ende
NEKTAR THERAPEUTICS	General Counsel	-

Sehen Sie sich die Erfahrung von Carlo J. di Fonzo im Detail an

Ausbildung von Carlo J. di Fonzo

University of Toronto

Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Carlo J. di Fonzo im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
NEKTAR THERAPEUTICS	Health Technology

Private Unternehmen	1
Vaneltix Pharma, Inc. Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ.	Health Technology